Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 2/20 | 0.37 |
| ▸ | ERN1 | O75460 | 2/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| P-Cymene SCHEMBL23296191 | 0.83 | TP53 (0.54) | TP53TSHRTYRBCHEACHE | |
| SCHEMBL29724084 | 0.80 | LMNA (0.50) | TYRERN1SRCTRPA1LMNA | |
| SCHEMBL10338935 | 0.80 | LMNA (0.50) | TYRERN1SRCTRPA1LMNA | |
| SCHEMBL29487262 | 0.80 | TSHR (0.61) | TP53TSHRTYRLMNA | |
| SCHEMBL1148 | 0.80 | TSHR (0.61) | TP53TSHRTYRLMNA | |
| SCHEMBL16268509 | 0.77 | TP53 (0.49) | TP53TSHRTYRBCHEACHE | |
| SCHEMBL31412800 | 0.74 | TP53 (0.63) | TP53TSHR | |
| SCHEMBL227153 | 0.74 | TP53 (0.63) | TP53TSHR | |
| SCHEMBL605235 | 0.73 | TYR (0.58) | TP53TSHRTYRERN1TRPA1 | |
| SCHEMBL2400864 | 0.71 | TSHR (0.51) | TP53TSHRTYRERN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140322156-A1 | PROCESS FOR REDUCING MALODOURS | HENKEL AG & CO. KGAA (DE) | 2014-10-30 | — | — | US | claimed |
| US-20140322156-A1 | PROCESS FOR REDUCING MALODOURS | HENKEL AG & CO. KGAA (DE) | 2014-10-30 | — | — | US | disclosed |
| US-20070256252-A1 | Fabric Treatment for Stain Release | CASELLA VICTOR M | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140322156-A1 | PROCESS FOR REDUCING MALODOURS | ALDH7A1, ACMSD, MAL2 | TP53 3326/4885TSHR 4414/4885TYR 28/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.